Pelage Pharmaceuticals raises $120M Series B for PP405 stem cell therapy in hair loss—Excedr covers this major biotech funding round.
Peptilogics raises $78M to develop AI-designed peptides for joint infections—Excedr covers this major biotech funding round.
Weave Bio’s $20M Series A accelerates AI automation in drug regulatory workflows—Excedr covers this major biotech funding round.
Exactics pioneers rapid, at-home infectious disease tests with its adaptable Proteus+ platform—Excedr covers this major biotech funding round.
Bexorg transforms CNS drug discovery with AI-powered whole-human brain platform—Excedr covers this major biotech funding round.
Lila Sciences pioneers autonomous AI labs, raising $550M to build scientific superintelligence—Excedr covers this major biotech funding round.
Kailera Therapeutics raises $1B to advance KAI-9531 obesity drug—Excedr covers this major biotech funding round.
Salt AI secures $10M funding to advance AI-powered drug discovery—Excedr covers this major biotech funding round.
Expedition Therapeutics secures $165M Series A to advance EXPD-101, a first-in-class oral DPP-1 inhibitor for COPD—Excedr covers this major biotech funding round.
Lumen Bioscience pioneers affordable oral biologic drugs using engineered spirulina—Excedr covers this major biotech funding round.
